Effects of extended aromatase inhibitors in women with hormone-dependent breast cancer who have already received five years of adjuvant hormone therapy: A systematic review and meta-analysis
DISCUSSION: Prolonged AI therapy has significant benefits in terms of disease-free survival in women with hormone-dependent breast cancer. However, adverse effects and a lack of evidence for a benefit on overall survival must be considered in the decision-making process regarding adjuvant hormone therapy extension.PMID:38453587 | DOI:10.1016/j.bulcan.2023.12.016
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Kossi Cl ément Trenou Miceline M ésidor Caroline Diorio Aida Eslami Denis Talbot Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Heart | Hormonal Therapy | Hormones | Men | Orthopaedics | Osteoporosis | Pain | Statistics | Study | Women